Navigation Links
Genetic Discovery May Improve Hepatitis C Treatment
Date:8/17/2009

Finding will help predict patient response to therapy, researchers say

MONDAY, Aug. 17 (HealthDay News) -- The first biomarker that predicts a patient's response to hepatitis C treatments has been identified by U.S. researchers.

The new marker is a single letter change -- a C instead of a T -- in a segment of DNA near the IL28B gene, according to the Duke University Medical Center team. They found it by studying the DNA of 1,671 people taking part in a study of hepatitis C treatments.

Not only does this biomarker predict who is most likely to respond to treatment and who isn't, it may solve the long-standing question of why responses to hepatitis C treatments vary so widely among racial and ethnic groups.

"For geneticists, understanding response to treatment for hepatitis C infection has been almost like a Holy Grail," study senior author David Goldstein, director of the Center for Human Genome Variation at Duke's Institute for Genome Sciences & Policy, said in a university news release.

"The side effects of hepatitis treatment can be brutal, and about half the time, the treatment fails to eradicate the virus. This discovery enables us to give patients valuable information that will help them and their doctors decide what is best for them. This is what personalized medicine is all about," Goldstein said.

The study appeared online Aug. 16 in the journal Nature.

Hepatitis C, one of the most common infections in the world, affects about 170 million people. Treatment typically involves 48 weeks of interferon plus the antiviral drug ribavirin. Black patients are less likely to respond to treatment than white patients, while East Asian patients seem to have the best response.

More information

The U.S. Centers for Disease Control and Prevention has more about hepatitis C.



-- Robert Preidt



SOURCE: Duke University Medical Center, news release, Aug. 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Genetic Link Suspected for Muscular Dystrophy
2. Carnegie Mellon develops innovative method to detect genetic causes of complex diseases
3. Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc.
4. March of Dimes Celebrates 50th Anniversary of Genetics Short Course
5. Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease
6. Genetic testing may be valuable in treating colorectal cancer
7. NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism: Fragile X
8. Studies Show Genetic Activity of Antioxidants
9. Genetic Variation Associated With Survival Advantage in African Americans With HIV
10. Study Shows a Link Between Schizophrenia & Genetic Mutations
11. Teen Behaviors Stem From Genetics, Environment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Discovery May Improve Hepatitis C Treatment
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name ... New York, NY, on December 3rd, to benefit Holy Name Medical Center's programs ... event, which raised over $1 million - the largest event in the Center's ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Cable Network (PCN) during the summer of 2016. The program was made possible ... the United States Department of Health and Human Services Administration. The broadcast, ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest Healthcare Properties ... by an affiliate of Seavest, has won a prestigious national healthcare real estate ... ambulatory care center (ACC) was named “Best New Development, MOBs and Other Outpatient ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, ... Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related to ... prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 with ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec 9, 2016 Research and Markets has ... report to their offering. ... The global travel vaccines market to grow at ... report covers the present scenario and the growth prospects of the ... the report considers the revenue generated from the sales of various ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... offer newly issued shares of common stock, $0.01 par value ... an underwritten public offering.  The final terms of the Offering ... of pricing, and there can be no assurance as to ... IRIDEX expects to use the net proceeds it will receive ...
Breaking Medicine Technology: